📰 Robert Kramer News
Page 24 - Robert Kramer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Robert Kramer. Real-time updates on events, politics, business and more.
April 10, 2021
CEO at troubled vaccine plant received 51 percent compensation boost in 2020 Christopher Rowland © Jim Lo Scalzo/EPA-EFE/REX/Shutterstock Mandatory Credit: Photo by JIM LO SCALZO/EPA-EFE/Shutterstock (11840686d) The biopharmaceutical company Emergent Biosolutions, where a mishap spoiled 15 million doses of Johnson & Johnsons coronavirus vaccine, in Baltimore, Maryland, USA, 01 April 2021. Mishap at Emergent Biosolutions ruins 15 million coronavirus vaccine doses, Baltimore, U...
April 6, 2021
(Beth LaBerge/KQED) Jocelyn Foreman was full of nervous energy and dread. It was a crisp morning in early March. She arrived at the Pleasant Hill Community Center to find a handful of men and women in a semicircle outside the sandstone-colored building, clutching folders and holding cell phones. They were there for a foreclosure auction, poised to bid on the house that Foreman rents: a single-story, 1,500-square-foot tract home in Pinole. It’s a simple home, set back from the street, with a...
April 5, 2021
Covid-19 Live Updates: Walgreens Wasnât Following U.S. Guidance on Pfizer Vaccine Spacing Last Updated April 5, 2021, 2:01 p.m. ETApril 5, 2021, 2:01 p.m. ET But following complaints, the pharmacy chain will start scheduling Pfizer vaccine doses three weeks apart. The Navajo Nation has managed to control what was once one of the worst outbreaks in the United States. But infections are rising nationally, and health officials are warning of another surge. Hereâs what you need to know: G...
April 5, 2021
Johnson & Johnson Takes Over Plant That Botched Vaccine Doses; AstraZeneca Looks For New Site By Ryan Chatelain Nationwide SHARE AstraZeneca is searching for a new manufacturer for its COVID-19 vaccine, part of the fallout after a Baltimore plant spoiled 15 million doses of Johnson & Johnson’s vaccine. What You Need To Know AstraZeneca is searching for a new manufacturer for its COVID-19 vaccine...
April 4, 2021
The Biden administration has stopped a Baltimore manufacturing plant from making AstraZenecas COVID vaccine after it ruined 15 million doses of Johnson & Johnsons.
March 10, 2021
BILT Partners with Bazaarvoice to Syndicate Reviews: 3D Assembly App Increases Ratings & User Generated Content Today consumers read online reviews to gather information before making a purchase. In a recent study, 15% of those asked said the assembly experience was the primary factor in their product decision. As ecommerce gains momentum and more products arrive with some assembly required, the out-of-the-box customer experience is becoming increasingly important. BILT provides 3D-guided set u...
March 8, 2021
America now knows that nursing homes are broken. Does anyone care enough to fix them? Suzy Khimm © Provided by NBC News The pandemic turned nursing homes into a death trap for more than 170,000 long-term care residents and staff members who have lost their lives to Covid-19. But the virus also revealed how America’s system for long-term care is fundamentally broken in ways that will continue to harm vulnerable residents and workers, long after the pandemic has faded away. Th...
March 8, 2021
White House scraps Biden vaccine event after report Baltimore company hogged stockpile funds Katherine Doyle © Provided by Washington Examiner A planned event headlined by President Biden celebrating vaccine developers Johnson & Johnson and Merck at a Baltimore-based federal contractor was moved to the White House following a report that the company drained the governments emergency stockpile of items. "We just felt it was a more appropriate place to have the meeting, but he ...
March 7, 2021
Government purchases for the Strategic National Stockpile, the country’s emergency medical reserve, have largely been driven by the demands and interests of a handful of biotech firms.
March 7, 2021
Government purchases for the Strategic National Stockpile, the country’s emergency medical reserve, have largely been driven by the demands and interests of a handful of biotech firms.